Aegis Spine, subsidiary of L&K BioMed, was granted FDA 510(k) clearance for AccelFix Expandable Cages. The devices launched in the U.S. earlier this month.
The system, pictured below, comprises sterile-packaged titanium alloy-based TLIF/PLIF cages (AccelFix-XT), an expandable lateral interbody (AccelFix-XL), and an Anterior-to-Psoas expandable interbody specifically contoured to avoid the contralateral nerve root (Accelfix-XTP).
AccelFix devices are complemented by a 5.5 rod spinal fixation system which earned FDA 510(k) clearance earlier this year.
Source: Aegis Spine, Inc.
Aegis Spine, subsidiary of L&K BioMed, was granted FDA 510(k) clearance for AccelFix Expandable Cages. The devices launched in the U.S. earlier this month.
The system, pictured below, comprises sterile-packaged titanium alloy-based TLIF/PLIF cages (AccelFix-XT), an expandable lateral interbody (AccelFix-XL), and an Anterior-to-Psoas...
Aegis Spine, subsidiary of L&K BioMed, was granted FDA 510(k) clearance for AccelFix Expandable Cages. The devices launched in the U.S. earlier this month.
The system, pictured below, comprises sterile-packaged titanium alloy-based TLIF/PLIF cages (AccelFix-XT), an expandable lateral interbody (AccelFix-XL), and an Anterior-to-Psoas expandable interbody specifically contoured to avoid the contralateral nerve root (Accelfix-XTP).
AccelFix devices are complemented by a 5.5 rod spinal fixation system which earned FDA 510(k) clearance earlier this year.
Source: Aegis Spine, Inc.
You’ve reached your limit.
We’re glad you’re finding value in our content — and we’d love for you to keep going.
Subscribe now for unlimited access to orthopedic business intelligence.
Copy to clipboard 
